Sublingual Immunotherapy In Alternaria-Induced Rhinitis
NCT01127035
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class
Conditions
Allergic Rhinitis (w/w Asthma) Due to Alternaria Alternata
Interventions
BIOLOGICAL:
sublingual immunotherapy
BIOLOGICAL:
placebo
Sponsor
University of Genova